Share on LinkedInShare on LinkedIn

ARTICLE · 28 NOVEMBER 2021

CCI Releases Its Market Study Findings On The Pharmaceutical Sector In India

Khaitan & Co.
Khaitan & Co.
Contributor
Khaitan & Co.

Khaitan & Co.

Founded in 1911, Khaitan & Co is a heritage law firm that has been a trusted adviser to leading...

View firm profile
Explore more from Khaitan & Co.

Within close to a year of initiation of its market study into the pharmaceutical sector, on 18 November 2021, the Competition Commission of India (CCI)...

IndiaAntitrust/Competition Law

Background

Within close to a year of initiation of its market study into the pharmaceutical sector, on 18 November 2021, the Competition Commission of India (CCI) released its findings in its report titled 'Market Study on the Pharmaceutical Sector in India: Key Findings and Observations'.1

Statistics reveal that the CCI has received 43 cases involving the pharmaceutical sector. The relentless flow of incoming cases in this space prompted the authority to examine the sector with the aim to understand discounts, margins, prevalence of branded generic drugs, wholesale and retail level distribution policies, role of trade associations, impact of e-commerce and online pharmacies on price and competition, among other aspects.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this document does not necessarily reflect the views / position of Khaitan & Co but remain solely those of the author(s). For any further queries or follow up, please contact Khaitan & Co at [email protected].

See more popular content from